JMDC Inc. (TSE:4483) agreed to acquire Cancer Scan Co., Ltd. for ¥ 14000 million on December 28, 2023. JMDC Inc. (TSE:4483) will acquire 0.11 million shares of Cancer Scan Co., Ltd. The total assets were ¥ 2695 million, net assets were ¥ 2,097 million, revenue was ¥ 4,177 million, operating profit was ¥ 696 million and net income was ¥ 454 million for year ending May 31, 2023 of Cancer Scan Co., Ltd. The deal is expected to be closed on January 31, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,270 JPY | +0.74% | +7.74% | -23.29% |
Feb. 05 | Omron Corp.'s Attributable Profit Declines 84.5% in Fiscal Nine Months | MT |
Feb. 05 | Jefferies Adjusts JMDC's Price Target to 5,700 Yen From 6,030 Yen, Keeps at Buy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.29% | 1.36B | |
+5.21% | 4.03B | |
+20.98% | 1.89B | |
0.00% | 1.84B | |
-3.22% | 1.71B | |
+3.13% | 1.63B | |
-16.98% | 1.58B | |
-7.67% | 1.16B | |
-4.66% | 1.05B | |
+119.33% | 694M |
- Stock Market
- Equities
- 4483 Stock
- News JMDC Inc.
- JMDC Inc. agreed to acquire Cancer Scan Co., Ltd. for ¥ 14000 million.